by Daniel X. Thomas
The patent relates to a enterically coated cysteamine bitartrate and cystamine composition useful for treating cystinosis and neurodegenerative diseases such as Huntington’s, Alzheimer’s and Parkinson’s disease,
The patent results from a divisional application of EP 1 919 458.
Brief outline of the case
The opposition was rejected and the opponent appealed.
by Daniel X. Thomas
Further to my comment of 06.04.2024 in the blog, there are recent news in this matter.
As far as EP 3 076 804 (T 439/22) is concerned, the minutes of the OP held on 10.04.2024 make clear that an interlocutory decision will be issued on 10.06.2024.
It is clear from the minutes that the board has decided a referral to the EBA on the application of Art 69 when interpreting claims in procedures before the EPO.
by Daniel X. Thomas
The patent relates to a control system with a plurality of spatially distributed stations and a method for transmitting data in said control system.
Brief outline of the case
The opposition was rejected and the opponent appealed.
The board held that claim 1 as granted was lacking IS over one of the A documents in the ISR established by the EPO and a book representing common general knowledge.
by Daniel X. Thomas
The patent relates to a cold rolled steel sheet and recrystallisation-annealed steel flat product and a method for producing the same.
Brief outline of the procedure
The patent was revoked by the OD as claim 1 as granted was infringing Art 123(2) and none of the AR were allowable.
The proprietor appealed the decision.
by Daniel X. Thomas
The patent relates to a breast tomosynthesis system, whereby the image quality is increased. The whole system allows optimisation of the pictures taken.
Brief outline of the case
The opposition was rejected and the opponent appealed the decision.
The board confirmed the revocation.
The discussion centred on the validity of the priority as the opponent alleged that between the priority and the granted claim,